CLINICAL_TRIALS
trial_result
· 2023-02-27
Clinical Trial Update: Phase II Study of BNC210 in PTSD [Phase 2]
Summary
Phase II study of BNC210 in post-traumatic stress disorder has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bionomics Limited | Conditions: Post-Traumatic Stress Disorder | Phase 2 | Status: COMPLETED | Results posted: 2023-02-27